GN Store Nord A/S (GN.CO)
DKK 94.26
(-0.06%)
DKK 94.26
(-0.06%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 21.05 Billion DKK | -11.49% |
| 2022 | 23.78 Billion DKK | 37.33% |
| 2021 | 17.32 Billion DKK | 50.58% |
| 2020 | 11.5 Billion DKK | -2.79% |
| 2019 | 11.83 Billion DKK | 49.4% |
| 2018 | 7.92 Billion DKK | 13.91% |
| 2017 | 6.95 Billion DKK | -3.62% |
| 2016 | 7.21 Billion DKK | 33.31% |
| 2015 | 5.41 Billion DKK | 18.63% |
| 2014 | 4.56 Billion DKK | 25.57% |
| 2013 | 3.63 Billion DKK | 36.73% |
| 2012 | 2.65 Billion DKK | -38.25% |
| 2011 | 4.3 Billion DKK | 30.31% |
| 2010 | 3.3 Billion DKK | 22.3% |
| 2009 | 2.7 Billion DKK | -19.91% |
| 2008 | 3.37 Billion DKK | 0.54% |
| 2007 | 3.35 Billion DKK | 0.78% |
| 2006 | 3.32 Billion DKK | 21.33% |
| 2005 | 2.74 Billion DKK | 85.4% |
| 2004 | 1.47 Billion DKK | -30.37% |
| 2003 | 2.12 Billion DKK | -32.55% |
| 2002 | 3.14 Billion DKK | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 19.56 Billion DKK | 0.58% |
| 2024 Q1 | 19.45 Billion DKK | -7.62% |
| 2023 Q4 | 21.05 Billion DKK | -1.27% |
| 2023 Q2 | 20.96 Billion DKK | -9.93% |
| 2023 FY | 21.05 Billion DKK | -11.49% |
| 2023 Q1 | 23.27 Billion DKK | -2.15% |
| 2023 Q3 | 21.32 Billion DKK | 1.72% |
| 2022 Q2 | 22.77 Billion DKK | 5.93% |
| 2022 FY | 23.78 Billion DKK | 37.33% |
| 2022 Q3 | 23.87 Billion DKK | 4.81% |
| 2022 Q4 | 23.78 Billion DKK | -0.36% |
| 2022 Q1 | 21.5 Billion DKK | 24.13% |
| 2021 Q3 | 11.9 Billion DKK | 3.84% |
| 2021 Q2 | 11.46 Billion DKK | 0.49% |
| 2021 Q1 | 11.41 Billion DKK | -0.82% |
| 2021 FY | 17.32 Billion DKK | 50.58% |
| 2021 Q4 | 17.32 Billion DKK | 45.5% |
| 2020 Q3 | 11.65 Billion DKK | 4.66% |
| 2020 Q1 | 10.84 Billion DKK | -8.36% |
| 2020 FY | 11.5 Billion DKK | -2.79% |
| 2020 Q2 | 11.13 Billion DKK | 2.64% |
| 2020 Q4 | 11.5 Billion DKK | -1.25% |
| 2019 Q1 | 9.18 Billion DKK | 15.93% |
| 2019 FY | 11.83 Billion DKK | 49.4% |
| 2019 Q4 | 11.83 Billion DKK | 17.47% |
| 2019 Q3 | 10.07 Billion DKK | 3.59% |
| 2019 Q2 | 9.72 Billion DKK | 5.9% |
| 2018 Q2 | 7.39 Billion DKK | 6.48% |
| 2018 FY | 7.92 Billion DKK | 13.91% |
| 2018 Q4 | 7.92 Billion DKK | 2.23% |
| 2018 Q3 | 7.74 Billion DKK | 4.73% |
| 2018 Q1 | 6.94 Billion DKK | -0.09% |
| 2017 FY | 6.95 Billion DKK | -3.62% |
| 2017 Q3 | 6.63 Billion DKK | 0.93% |
| 2017 Q2 | 6.57 Billion DKK | -1.11% |
| 2017 Q1 | 6.64 Billion DKK | -7.91% |
| 2017 Q4 | 6.95 Billion DKK | 4.87% |
| 2016 Q4 | 7.21 Billion DKK | 11.17% |
| 2016 Q1 | 5.59 Billion DKK | 3.33% |
| 2016 FY | 7.21 Billion DKK | 33.31% |
| 2016 Q2 | 5.68 Billion DKK | 1.72% |
| 2016 Q3 | 6.49 Billion DKK | 14.1% |
| 2015 Q3 | 5.32 Billion DKK | 0.38% |
| 2015 Q1 | 5.28 Billion DKK | 15.78% |
| 2015 Q2 | 5.3 Billion DKK | 0.38% |
| 2015 Q4 | 5.41 Billion DKK | 1.69% |
| 2015 FY | 5.41 Billion DKK | 18.63% |
| 2014 Q2 | 3.97 Billion DKK | 3.16% |
| 2014 Q4 | 4.56 Billion DKK | 5.99% |
| 2014 Q3 | 4.3 Billion DKK | 8.17% |
| 2014 FY | 4.56 Billion DKK | 25.57% |
| 2014 Q1 | 3.85 Billion DKK | 6.17% |
| 2013 Q3 | 3.46 Billion DKK | 3.62% |
| 2013 Q4 | 3.63 Billion DKK | 4.94% |
| 2013 FY | 3.63 Billion DKK | 36.73% |
| 2013 Q1 | 3.07 Billion DKK | 15.54% |
| 2013 Q2 | 3.34 Billion DKK | 8.83% |
| 2012 Q2 | 2.7 Billion DKK | 3.44% |
| 2012 Q1 | 2.61 Billion DKK | -39.21% |
| 2012 FY | 2.65 Billion DKK | -38.25% |
| 2012 Q4 | 2.65 Billion DKK | -1.81% |
| 2012 Q3 | 2.7 Billion DKK | 0.0% |
| 2011 Q1 | 3.39 Billion DKK | 2.73% |
| 2011 FY | 4.3 Billion DKK | 30.31% |
| 2011 Q4 | 4.3 Billion DKK | 21.55% |
| 2011 Q2 | 3.37 Billion DKK | -0.56% |
| 2011 Q3 | 3.54 Billion DKK | 4.95% |
| 2010 Q2 | 2.82 Billion DKK | 5.42% |
| 2010 FY | 3.3 Billion DKK | 22.3% |
| 2010 Q1 | 2.67 Billion DKK | -0.89% |
| 2010 Q3 | 3.31 Billion DKK | 17.44% |
| 2010 Q4 | 3.3 Billion DKK | -0.33% |
| 2009 Q4 | 2.7 Billion DKK | 0.0% |
| 2009 FY | 2.7 Billion DKK | -19.91% |
| 2008 FY | 3.37 Billion DKK | 0.54% |
| 2007 FY | 3.35 Billion DKK | 0.78% |
| 2006 FY | 3.32 Billion DKK | 21.33% |
| 2005 FY | 2.74 Billion DKK | 85.4% |
| 2004 FY | 1.47 Billion DKK | -30.37% |
| 2003 FY | 2.12 Billion DKK | -32.55% |
| 2002 FY | 3.14 Billion DKK | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Ambu A/S | 1.46 Billion DKK | -1336.221% |
| ChemoMetec A/S | 111.35 Million DKK | -18807.657% |
| Demant A/S | 21.2 Billion DKK | 0.721% |
| Scandinavian Medical Solutions A/S | 89.51 Million DKK | -23421.752% |
| ViroGates A/S | 7.54 Million DKK | -278848.066% |